Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2005, Vol. 105, No. 10, pp. 3918-3924.
Prepublished online as a Blood First Edition Paper on February 8, 2005; DOI 10.1182/blood-2004-09-3689.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-09-3689v1
105/10/3918    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dangelmaier, C. A
Right arrow Articles by Daniel, J. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dangelmaier, C. A
Right arrow Articles by Daniel, J. L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted September 23, 2004
Accepted January 17, 2005

Rapid ubiquitination of Syk following GPVI activation in platelets

Carol A Dangelmaier, Patricia G Quinter, Jianguo Jin, Alexander Y Tsygankov, Satya P Kunapuli, and James L Daniel*

Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Center, Temple University School of Medicine, Philadelphia, PA, USA
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Center, Temple University School of Medicine, Philadelphia, PA, USA

* Corresponding author; email: jdaniel{at}temple.edu.

Syk activation is a key intermediate step in the activation of platelets by the physiologic agonist collagen. We have found that Syk is rapidly ubiquitinated upon activation of platelets by collagen, CRP and convulxin. The Src family kinase inhibitors prevented Syk phosphorylation and its ubiquitination, indicating that the process is downstream of Src kinases. The ubiquitination of Syk did not cause degradation of the protein as evidenced by the lack of effect of proteasomal and lysosomal inhibitors. We separated ubiquitinated Syk from its non-ubiquitinated counterpart and used an in vitro kinase assay to compare their activities. We found that the ubiquitinated Syk appeared to be about five-fold more active. Using a phosphospecific antibody to Syk (Tyr525/Tyr526) that measures activated Syk, we found that the majority (60-75%) of the active Syk is in the ubiquitinated fraction. This result explains the apparent high specific activity of ubiquitinated Syk. In c-Cbl deficient mice, Syk is not ubiquitinated implicating c-Cbl as the E3 ligase involved in Syk ubiquitination. Furthermore, Syk is not dephosphorylated in these mice. We propose that c-Cbl plays a regulatory role in GPVI/FcR[[gamma]-chain-dependent platelet activation through its interaction with Syk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
R. Nakao, K. Hirasaka, J. Goto, K. Ishidoh, C. Yamada, A. Ohno, Y. Okumura, I. Nonaka, K. Yasutomo, K. M. Baldwin, et al.
Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading
Mol. Cell. Biol., September 1, 2009; 29(17): 4798 - 4811.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. S. Bynagari, B. Nagy Jr., F. Tuluc, K. Bhavaraju, S. Kim, K. V. Vijayan, and S. P. Kunapuli
Mechanism of Activation and Functional Role of Protein Kinase C{eta} in Human Platelets
J. Biol. Chem., May 15, 2009; 284(20): 13413 - 13421.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Wang, L. Simeoni, J. A. Lindquist, J. Saez-Rodriguez, A. Ambach, E. D. Gilles, S. Kliche, and B. Schraven
Dynamics of Proximal Signaling Events after TCR/CD8-Mediated Induction of Proliferation or Apoptosis in Mature CD8+ T Cells
J. Immunol., May 15, 2008; 180(10): 6703 - 6712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. A. Karim, W. Choi, and S. W. Whiteheart
Primary Platelet Signaling Cascades and Integrin-mediated Signaling Control ADP-ribosylation Factor (Arf) 6-GTP Levels during Platelet Activation and Aggregation
J. Biol. Chem., May 2, 2008; 283(18): 11995 - 12003.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Rabie, D. Varga-Szabo, M. Bender, R. Pozgaj, F. Lanza, T. Saito, S. P. Watson, and B. Nieswandt
Diverging signaling events control the pathway of GPVI down-regulation in vivo
Blood, July 15, 2007; 110(2): 529 - 535.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020